Profile
SABS VRTX REGN ALNY SGEN ARGX
Company Name SAB Biotherapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $25.92M $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 0.06K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Samuel J. Reich Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
SABS VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
SABS VRTX REGN ALNY SGEN ARGX
Last Close $2.79 $469.55 $547.93 $322.81 $228.74 $577.92
High 52 $4.65 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $1.11 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -40 % -9.13 % -54.41 % -2.74 % 0 % -13.97 %
Price vs. 52 Week Low 151.35 % 18.38 % 13.46 % 43.74 % 0 % 25.36 %
Total Return
SABS VRTX REGN ALNY SGEN ARGX
1 Month Return 56.74 % 6.24 % 7.65 % 4.54 % 0 % 6.88 %
3 Month Return 94.43 % -4 % -2.7 % 37.62 % 0 % -3.07 %
6 Month Return -20.96 % 11.27 % -19.61 % 31.08 % 0 % -9.77 %
9 Month Return 1.09 % -5.85 % -45.09 % 8.8 % 0 % 6.37 %
YTD Return -26.47 % 16.6 % -23.08 % 37.18 % 0 % -6.03 %
1 Year Return -4.45 % -3.85 % -49.53 % 34.49 % 0 % 24.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SABS VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -150.87 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
SABS VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 275.3 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -89.92 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -105.14 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -148.57 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 81.05 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -11193.25 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -463.04 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 17.67 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 0.41 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 1.77 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 0.99 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -3.38 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -3.4 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 138.3 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -8312.6 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.66 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -463.04 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.82 -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -0.83 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -0.83 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
SABS VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio -262.48% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.03B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -3.68 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
SABS VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.03B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.01B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.04B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
SABS VRTX REGN ALNY SGEN ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.425
AARD Aardvark Therapeutics, Inc. Common Stock 12.03
ABCL AbCellera Biologics Inc. 3.895
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.63
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.5
ABPWW 0.0225
ABSI Absci Corporation 2.885
ABUS Arbutus Biopharma Corporation 3.135
ABVC ABVC BioPharma, Inc. 3.57
ABVX Abivax SA American Depositary Shares 10.32
ACAD ACADIA Pharmaceuticals Inc. 22.57
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7911
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.75
ACIU AC Immune SA 2.07
ETFs With Exposure to SABS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 309.245
BIB ProShares Ultra Nasdaq Biotechnology 0 50.61
VXF Vanguard Extended Market Index Fund 0 198.5
IWC iShares Micro-Cap ETF 0.00018 134.365
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.51
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.49
GERM ETFMG Treatments, Testing and Advancements ETF 0.06 19.1577
SPAK Defiance Next Gen SPAC Derived ETF 0.05 14.63
IBBQ Invesco Nasdaq Biotechnology ETF 0 22.26
VTSAX Vanguard Total Stock Market Index Fund 0 149.59
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 6.5125
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 148.84
VITSX Vanguard Total Stock Market Index Fund 0 149.62
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000183485 105.85
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 148.85
VEMPX Vanguard Extended Market Index InstlPlus 0 367.31
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 280.66
Unlock